In 2017, a group of partners, brought together by Funders Concerned About AIDS and including Gilead Sciences, Ford Foundation, the Elton John AIDS Foundation, ViiV Healthcare, and Johnson and Johnson, launched the Southern HIV Impact Fund. The Fund is administered by AIDS United – the nation’s leading organization advocating for a coordinated response to HIV in partnership with community-based groups around the country.

AIDS United is a national non-profit organization focused on ending the AIDS epidemic in the United States through strategic grant-making, capacity building, and policy and advocacy.

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

The Ford Foundation funds innovative ideas, visionary individuals, and frontline institutions advancing human dignity around the world.

The Elton John Foundation funds frontline programs that help to alleviate the pain of those living with, affected by or at risk of HIV worldwide.

Viiv Healthcare is an independent, global specialist HIV company committed to delivering innovative new options for the care and treatment of people living with HIV.

Johnson & Johnson is a pharmaceutical company that strives to discover and develop novel therapeutics and vaccines to treat and cure infectious diseases worldwide, improving treatment outcomes and patients’ lives.